Lightspeed Microscopy, Inc. raises $4M in Series A Financing Round with Plans to Revolutionize Pathology

Lightspeed Microscopy, Inc., an end-to-end 3D pathology platform, announced today it has raised $4 million in a Series A financing round.  The round was led by Dynamk Capital and is expected to close with participation from additional investors by mid-July. Lightspeed The new funding will be used to commercialize and scale Lightspeed's microscopy platform. Lightspeed's technology combines novel chemistry, patented open-top light-sheet microscopy, and cloud-based AI data analysis to non-destructively image large tissues in 3D at a sub-cellular resolution. The platform is a complete solution that includes tissue labelling, tissue clearing, high-throughput imaging, cloud-based processing, and 3D digital analysis. Together, these technologies greatly improve the accuracy and speed of preclinical testing while creating compelling new insights.
（以上内容由医药魔方AI生成）